We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+4.84%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.43B
AUM Growth
+$75.3M
Cap. Flow
-$42M
Cap. Flow %
-1.22%
Top 10 Hldgs %
13.83%
Holding
1,352
New
131
Increased
487
Reduced
534
Closed
83

Top Sells

Rank Stock Value
1
GE icon
GE Aerospace
GE
+$9.73M
2
MSFT icon
Microsoft
MSFT
+$6.54M
3
LMT icon
Lockheed Martin
LMT
+$5.54M
4
DD icon
DuPont de Nemours
DD
+$5.19M
5
AAPL icon
Apple
AAPL
+$4.57M

Sector Composition

Rank Sector Weight
1 Healthcare 14.45%
2 Technology 10.24%
3 Financials 10.23%
4 Industrials 9%
5 Consumer Discretionary 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ULTA icon
176
Ulta Beauty
ULTA
$20.4B
$4.63M 0.13%
19,437
+1,242
+7% +$314K
CWB icon
177
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.64B
$4.61M 0.13%
99,455
-211
-0.2% -$9.63K
NOV icon
178
NOV
NOV
$7.45B
$4.61M 0.13%
125,401
-510
-0.4% -$17.1K
SHW icon
179
Sherwin-Williams
SHW
$78.3B
$4.6M 0.13%
49,887
-9,537
-16% -$925K
PYPL icon
180
PayPal
PYPL
$49.5B
$4.59M 0.13%
112,071
+12,028
+12% +$462K
GLW icon
181
Corning
GLW
$126B
$4.51M 0.13%
190,738
+10,335
+6% +$230K
ESRX
182
DELISTED
Express Scripts Holding Company
ESRX
$4.48M 0.13%
63,590
+4,817
+8% +$360K
TGT icon
183
Target
TGT
$62.1B
$4.43M 0.13%
64,553
-14,286
-18% -$1.02M
OKE icon
184
Oneok
OKE
$58.7B
$4.4M 0.13%
85,550
+28,207
+49% +$1.33M
AMBR
185
DELISTED
Amber Road Inc
AMBR
$4.37M 0.13%
453,075
+64,000
+16% +$611K
MDLZ icon
186
Mondelez International
MDLZ
$77.7B
$4.36M 0.13%
99,426
+5,088
+5% +$223K
WYNN icon
187
Wynn Resorts
WYNN
$10.1B
$4.33M 0.13%
44,411
+35,895
+422% +$3.5M
PX
188
DELISTED
Praxair Inc
PX
$4.31M 0.13%
35,658
-485
-1% -$57.4K
GSK icon
189
GSK
GSK
$103B
$4.25M 0.12%
78,882
+3,108
+4% +$170K
MKC icon
190
McCormick & Company Non-Voting
MKC
$13.4B
$4.24M 0.12%
84,862
-4,078
-5% -$207K
DAL icon
191
Delta Air Lines
DAL
$55.9B
$4.18M 0.12%
106,184
+12,721
+14% +$481K
DFS
192
DELISTED
Discover Financial Services
DFS
$4.16M 0.12%
73,519
+10,652
+17% +$610K
EPI icon
193
WisdomTree India Earnings Fund ETF
EPI
$2.02B
$4.09M 0.12%
189,326
-12,050
-6% -$258K
CL icon
194
Colgate-Palmolive
CL
$72.6B
$4.09M 0.12%
55,186
-226
-0.4% -$16.7K
UNIT
195
Uniti Group
UNIT
$2.63B
$4.09M 0.12%
130,088
+3,636
+3% +$112K
BCE icon
196
BCE
BCE
$19.9B
$4.08M 0.12%
88,440
-111
-0.1% -$5.26K
CME icon
197
CME Group
CME
$92.2B
$4.03M 0.12%
38,525
-2,217
-5% -$231K
UPS icon
198
United Parcel Service
UPS
$97.6B
$4.02M 0.12%
36,799
-4,011
-10% -$438K
PANW icon
199
Palo Alto Networks
PANW
$264B
$4.02M 0.12%
151,386
+12,132
+9% +$276K
GHDX
200
DELISTED
Genomic Health, Inc.
GHDX
$4.01M 0.12%
138,749
-3,000
-2% -$83.6K

Similar funds

Oppenheimer & Co's Q3 2016 Portfolio in Review

As of Q3 2016, Oppenheimer & Co held 1,352 positions worth $3.43B, up 2.2% from $3.35B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co's Q3 2016 filing shows 131 new, 487 increased, 534 reduced and 83 closed positions. Its largest new stake was Brookfield Infrastructure Partners: 168,877 shares worth $3.48M. The largest sale was GE Aerospace, an estimated $9.73M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 15% a quarter earlier, followed by Technology and Financials.

  • Oppenheimer & Co's largest Q3 2016 buy was Brookfield Infrastructure Partners: 168,877 shares worth $3.48M.
  • Oppenheimer & Co added most to Bristol-Myers Squibb in Q3 2016, an estimated $6.72M increase.
  • Oppenheimer & Co's biggest Q3 2016 reduction was GE Aerospace, cutting an estimated $9.73M.
  • Oppenheimer & Co fully exited Agrium in Q3 2016, selling an estimated $3.32M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.43B portfolio in Q3 2016.
  • Oppenheimer & Co opened 131 new positions and closed 83 in Q3 2016.
  • Oppenheimer & Co's portfolio value rose 2.2% quarter-over-quarter to $3.43B.

Based on Oppenheimer & Co's 13F filing for Q3 2016, filed 7 Nov 2016.